Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer.
Craig Ramsay(University of Aberdeen), Naeem Soomro, Tara Gurung, Cynthia Fraser, Clare Robertson, Robert Pickard, CG Eden, Andrew Close, G Mowatt, Pawana Sharma(University of Birmingham), Nigel Armstrong(Kleijnen Systematic Reviews (United Kingdom)), Daniel A. Barocas(Vanderbilt University Medical Center), D Jenkinson(Brain Tumour Charity), David E. Neal(University of Cambridge), TB Lam, MC Robinson, J Royle(Nutrition Sciences (Belgium)), Xueli Jia(Fourth People's Hospital of Sichuan Province), SP Rushton, Luke Vale(London School of Hygiene & Tropical Medicine)
Cited by 256
Related Papers
The evolutionary history of lethal metastatic prostate cancer
|Nature|2015|1.4k
Multiple newly identified loci associated with prostate cancer susceptibility
|Nature Genetics|2008|850
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592
Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline
|The Journal of Urology|2012|487